日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

HES V2.0 validation and performance compared to GALAD and ASAP in the HEDS cohort

HES V2.0 在 HEDS 队列中的验证和性能与 GALAD 和 ASAP 的比较

El-Serag, Hashem B; Lopez, Camden; Luster, Michelle; Reddy, K Rajender; Parikh, Neehar; Singal, Amit G; Marrero, Jorge A; Thrift, Aaron P; Chhatwal, Jagpreet; Feng, Ziding; Page-Lester, Stephanie; Jin, Qingchun; Tayob, Nabihah; Kanwal, Fasiha

Quantitative HER2 tissue and plasma profiling predicts the activity of trastuzumab deruxtecan for breast cancer.

定量 HER2 组织和血浆分析可预测曲妥珠单抗 deruxtecan 对乳腺癌的活性。

Tarantino Paolo, Kim Se-Eun, Hughes Melissa E, Kusmick Ross J, Smith Kalie, Brasó-Maristany Fara, Nyein Chan Nay Nwe, Paré Brunet Laia, Alder Laura, Garcia-Cortes Diana, Gomez Tejeda Zanudo Jorge, Pereslete Alyssa M, Noteware Laura, Moore Heather, Van Swearingen Amanda E D, Li Tianyu, Gupta Hersh, D'Amico Olivia, Martini Alba, Morganti Stefania, Spindel Jennifer, Cook Charmaine, McLaughlin Christine, Dvir Kathrin, Garrido-Castro Ana C, Sammons Sarah, Files Janet, Sendrick Kerry, Buck Simone, Dillon Deborah, Jeselsohn Rinath, Li Yvonne Y, Cherniack Andrew D, LoRusso Patricia, Lustberg Maryam, Vega-León Rosario, Pardo Francisco, Davis Justin, Mueller Claudius, Corgiat Brian, Curigliano Giuseppe, Anders Carey K, Petricoin Emanuel F, Rimm David L, Prat Aleix, Tayob Nabihah, Lin Nancy U, Tolaney Sara M

Impact of pathologic response and individual prognosis after neoadjuvant treatment in patients with early HER2+ and triple-negative breast cancer

新辅助治疗后病理反应及个体预后对早期HER2阳性及三阴性乳腺癌患者的影响

Corti, Chiara; Li, Tianyu; Martin, Alyssa R; Hughes, Melissa E; Parker, Tonia; Duporte, Tyzaire S; Curigliano, Giuseppe; King, Tari A; Mittendorf, Elizabeth A; Lin, Nancy U; Tayob, Nabihah; Tolaney, Sara M

Androgen receptor expression and immune characteristics of HER2-low metastatic triple-negative breast cancer

HER2低表达转移性三阴性乳腺癌的雄激素受体表达和免疫特征

Tarantino, Paolo; Cha, Jaeyoon; Binboga Kurt, Busem; Chu, Xiangying; Jovanović, Bojana; Zhou, Andrew; Hughes, Melissa; Russo, Douglas; DiLullo, Molly; Wrabel, Eileen; Jeselsohn, Rinath; Lin, Nancy U; Carter, Jamie; Chen, Yisang Serenity; Li, Tianyu; Tayob, Nabihah; Mittendorf, Elizabeth A; Schnitt, Stuart J; Goel, Shom; Tolaney, Sara M

Prognostic value of visually and computationally assessed tumor-infiltrating lymphocytes in early-stage triple-negative breast cancer (TBCRC-030)

视觉和计算机评估的肿瘤浸润淋巴细胞在早期三阴性乳腺癌中的预后价值(TBCRC-030)

Nader-Marta, Guilherme; Chu, Xiangying; Mukhopadhyay, Satabhisa; Abramson, Vandana G; Brufsky, Adam; Stringer-Reasor, Erica Michelle; Dent, Susan Faye; Traina, Tiffany A; Carey, Lisa A; Rimawi, Mothaffar F; Specht, Jennifer M; Miller, Kathy D; Santa-Maria, Cesar Augusto; Dasgupta, Tathagata; Kurt, Busem Binboğa; DeMeo, Michelle; Krop, Ian E; Tung, Nadine M; Schnitt, Stuart J; Tayob, Nabihah; Mayer, Erica L

Validation of longitudinal biomarker screening algorithms for HCC detection in patients with cirrhosis

验证纵向生物标志物筛查算法在肝硬化患者肝细胞癌检测中的应用

Singal, Amit G; Jin, Qingchun; Marrero, Jorge; Parikh, Neehar D; Lok, Anna S; Lopez, Camden; Page-Lester, Stephanie; Roberts, Lewis R; Reddy, Rajender; Luster, Michelle; Khaderi, Saira; Asrani, Sumeet K; El-Serag, Hashem B; Kanwal, Fasiha; Feng, Ziding; Tayob, Nabihah

A phase II study of atezolizumab in combination with stereotactic radiation for patients with triple-negative breast cancer and brain metastasis

一项针对三阴性乳腺癌脑转移患者的阿特珠单抗联合立体定向放射治疗的II期研究

Giordano, Antonio; Graham, Noah; Aizer, Ayal A; Tayob, Nabihah; Pereslete, Alyssa M; Schoenfeld, Jonathan D; Leone, Jose Pablo; Davis, Raechel; Erick, Timothy K; Mayer, Erica L; Winer, Eric P; Krop, Ian; Tolaney, Sara M; Lin, Nancy U

The role of ulnar nerve hypermobility in the etiology of ulnar nerve neuropathy at the elbow - A retrospective cohort study

尺神经活动度过大在肘部尺神经病变病因学中的作用——一项回顾性队列研究

Garozzo, Debora; Abusharbain, Eman; Alzahmi, Fatma; Cocco, Giovanni; Alhoot, Shahad; Gefe, Dana; Saleh, Kenan; Tayob, Muhammed; Sait, Ruzaina; Rana, Khizer

A Phase 3 Biomarker Validation of GALAD for the Detection of Hepatocellular Carcinoma in Cirrhosis

GALAD作为肝硬化患者肝细胞癌检测标志物的III期生物标志物验证研究

Marsh, Tracey L; Parikh, Neehar D; Roberts, Lewis R; Schwartz, Myron E; Nguyen, Mindie H; Befeler, Alex; Page-Lester, Stephanie; Tayob, Nabihah; Srivastava, Sudhir; Rinaudo, Jo Ann; Singal, Amit G; Reddy, K Rajender; Marrero, Jorge A

HES V2.0 outperforms GALAD for detection of HCC: A phase 3 biomarker study in the United States

HES V2.0 在检测肝细胞癌方面优于 GALAD:一项在美国进行的 3 期生物标志物研究

El-Serag, Hashem B; Jin, Qingchun; Tayob, Nabihah; Salem, Emad; Luster, Michelle; Alsarraj, Abeer; Khaderi, Saira; Singal, Amit G; Marrero, Jorge A; Asrani, Sumeet K; Kanwal, Fasiha